Smart patch: compared to hypodermic single needles, a ‘smart patch’ consists of a collection of tiny needles - microneedles - created to break the skin barrier in a minimally invasive manner, similar to a nicotine patch. Their innovative design means they can be developed to identify and monitor specific biomarkers in the skin. (IMAGE)

Swansea University

Smart patch: compared to hypodermic single needles, a ‘smart patch’ consists of a collection of tiny needles - microneedles - created to break the skin barrier in a minimally invasive manner, similar to a nicotine patch. Their innovative design means they can be developed to identify and monitor specific biomarkers in the skin.

Caption

Scientists from Swansea University ‘s Institute for Innovative Materials, Processing and Numerical Technologies (IMPACT) and Japan have been awarded £1.3 million to develop a new “point of care testing” kit that can detect biomarkers for Alzheimer's Disease. The project follows Dr Sanjiv Sharma’s ground-breaking work in this area and the development of the world’s first COVID-19 ‘smart patch’.

Credit

Swansea University

Usage Restrictions

Use with credit as below

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.